Paul J. Harasymowycz
NEW ORLEANS — Two-year results of the HORIZON study show that 77.2% of patients implanted with a Hydrus microstent achieved the primary endpoint of a 20% reduction in washed-out IOP compared with 57.8% of patients who underwent cataract surgery only.
In the HORIZON study, 556 patients with cataract and mild to moderate glaucoma were randomly assigned to cataract surgery with the Hydrus (Ivantis) or to cataract surgery alone.
“Whenever we do combined surgery, the cataract effect weans off over time and perhaps that’s why these stents are working,” Paul
Uncategorized